VANTEPTI Trademark

Trademark Overview

On Tuesday, April 24, 2018, a trademark application was filed for VANTEPTI with the United States Patent and Trademark Office. The USPTO has given the VANTEPTI trademark a serial number of 87890408. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 20, 2021. This trademark is owned by Alder BioPharmaceuticals, Inc.. The VANTEPTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, and neurological disorders and conditions
vantepti

General Information

Serial Number87890408
Word MarkVANTEPTI
Filing DateTuesday, April 24, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 20, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, and neurological disorders and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98011
Party NameAlder BioPharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98011
Party NameAlder BioPharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98011

Trademark Events

Event DateEvent Description
Monday, December 20, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 20, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, April 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 29, 2021SOU EXTENSION 5 GRANTED
Thursday, April 8, 2021SOU EXTENSION 5 FILED
Thursday, April 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 8, 2021TEAS EXTENSION RECEIVED
Tuesday, October 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 9, 2020SOU EXTENSION 4 GRANTED
Friday, October 9, 2020SOU EXTENSION 4 FILED
Friday, October 9, 2020TEAS EXTENSION RECEIVED
Wednesday, April 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 27, 2020SOU EXTENSION 3 GRANTED
Monday, April 27, 2020SOU EXTENSION 3 FILED
Monday, April 27, 2020TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, November 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2019SOU EXTENSION 2 GRANTED
Wednesday, November 6, 2019SOU EXTENSION 2 FILED
Wednesday, November 6, 2019TEAS EXTENSION RECEIVED
Saturday, April 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2019SOU EXTENSION 1 GRANTED
Thursday, April 11, 2019SOU EXTENSION 1 FILED
Thursday, April 11, 2019TEAS EXTENSION RECEIVED
Tuesday, November 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 15, 2018ASSIGNED TO EXAMINER
Thursday, May 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 27, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

vantepti disorders inflammatory immune diseases conditions neurological pain migraines used preparations